Ticker LaunchReverse merger · Completed · EMMA
Emmaus Life Sciences, Inc.
Reverse merger with MYnd Analytics, Inc.
Emmaus Life Sciences, Inc. merged into MYnd Analytics, Inc., a telepsychiatry business spun off to MYnd shareholders as Telemynd before the merger, in a reverse merger that takes the private company public. The deal was announced on Jan 4, 2019 and closed on Jul 17, 2019. The combined company trades as Emmaus Life Sciences, Inc. (EMMA) on OTC.
Emmaus Life Sciences is a commercial-stage biopharmaceutical company focused on the development, marketing and sale of innovative treatments and therapies, including those for rare and orphan diseases.
- Status
- Completed
- Private company
- Emmaus Life Sciences, Inc.
- Public company
- MYnd Analytics, Inc.
- Public company business before
- telepsychiatry business spun off to MYnd shareholders as Telemynd before the merger
- Announced
- Jan 4, 2019
- Closed
- Jul 17, 2019
- Combined company
- Emmaus Life Sciences, Inc. (EMMA)
- Exchange
- OTC
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Closing 8-K Jul 22, 2019
- Closing press release
- Announcement 8-K Sep 26, 2018
- All filings on EDGAR CIK 822370
Other completed reverse mergers
- Stabilis Energy LLCinto American Electric Technologies, Inc. · Jul 26, 2019
- Patagonia Gold Plcinto Hunt Mining Corp. · Jul 22, 2019
- Salarius Pharmaceuticals, LLCinto Flex Pharma, Inc. · Jul 19, 2019
- Hire Quest Holdings, LLCinto Command Center, Inc. · Jul 15, 2019
- Jin Wan Hong (BVI) International Holdings Limitedinto Jin Wan Hong International Holdings Limited · Jul 15, 2019
- NeuBase Therapeutics, Inc.into Ohr Pharmaceutical, Inc. · Jul 12, 2019